CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor …GlobeNewswire (press release)ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a genome edit… Continue reading
Jounce Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 32nd Annual MeetingGlobeNewswire (press release)CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-st… Continue reading
The Pharma LetterCell and gene therapies offer promise, but face market access challengesThe Pharma LetterIn light of the progress and potential of cell and gene therapies, Amy Grogg, senior vice president of strategy and communication at US drug whole… Continue reading
Medical XpressInner ear stem cells may someday restore hearingMedical XpressA stem cell-derived neuron grafted onto a mouse cochlea in the inner ear that lacked neurons. The new neuron is marked red, hair cells that convert sounds into neural signals a… Continue reading
Medgadget (blog)Rising Prevalence of Cancer to Drive the Growth of Immunotherapy Drug Market in Future, According to Research Nester.Medgadget (blog)The global immunotherapy drug market is segmented into drug types such as antibodies, interleukins, int… Continue reading
Medgadget (blog)Rising Prevalence of Cancer to Drive the Growth of Immunotherapy Drug Market in Future, According to Research Nester.Medgadget (blog)The global immunotherapy drug market is segmented into drug types such as antibodies, interleukins, int… Continue reading
Deccan Chronicle |
Scientists ‘completely cure’ bowel cancer with new form of immunotherapy
Deccan Chronicle Researchers from Memorial Sloan Kettering Cancer Centre (MSKCC) in New York and Massachusetts Institute of Technology in Boston, developed a new type of radioimmunotherapy (RIT) which is a combination of immunotherapy and radiation treatment. |
Deccan Chronicle |
Scientists ‘completely cure’ bowel cancer with new form of immunotherapy
Deccan Chronicle Researchers from Memorial Sloan Kettering Cancer Centre (MSKCC) in New York and Massachusetts Institute of Technology in Boston, developed a new type of radioimmunotherapy (RIT) which is a combination of immunotherapy and radiation treatment. |